Table 1. The breakdown of NASH and non-NASH patients according to serum AST level below and above the upper limit of normal, and serum AST level below and above two times the upper limit of normal, in a cohort of biopsy-proven NAFLD patients.
AST level (IU/L) | Non-NASH | NASH | Total |
---|---|---|---|
The upper limit of normal | |||
AST <37 | 6 | 35 | 41 |
AST ≥37 | 4 | 48 | 52 |
Total | 10 | 83 | 93 |
Two times the upper limit of normal | |||
AST <74 | 10 | 67 | 77 |
AST ≥74 | 0 | 16 | 16 |
Total | 10 | 83 | 93 |
Note: (I) a complete description of the study population is published elsewhere (9); (II) the diagnosis of NASH was based on pathologist global assessment; (III) the upper limit of normal of serum AST level at the author’s institution is 37 IU/L. AST, aspartate aminotransferase; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis.